Vertex’s Upgraded IgA Nephropathy Outlook Might Change The Case For Investing In Vertex (VRTX)

In the past week, Wolfe Research upgraded Vertex Pharmaceuticals from “Peer Perform” to “Outperform,” citing growing ...
Reuters

Vertex Confirms Supply Chain Continuity And Business Outlook For Its Cystic Fibrosis Medicines And Provides Initial Update On Development Programs

* VERTEX PHARMACEUTICALS INC - TOO EARLY TO PRECISELY DETERMINE LONG-TERM EFFECTS OF OUTBREAK ON TRIAL TIMELINES. * VERTEX PHARMACEUTICALS INC - HAS AMPLE SUPPLY TO MEET COMMERCIAL NEEDS WELL INTO ...